AbbVie

Official global handle sharing the latest news about our company, science & people. Review our guidelines:

[AbbVie @abbvie]

At @EHA_Hematology, we’ll be showcasing our clinical advancements across multiple blood cancers and connecting with the global community. https://t.co/u1xNRYNPrO

[AbbVie @abbvie]

At #EULAR2026, conversations on the ground are focused on how to achieve and maintain disease control in #PsA and #axSpA. AbbVie is on-site, sharing new research and a commitment to improving patient outcomes. Learn more: https://t.co/H2rNBLvGuV

[AbbVie @abbvie]

[Animation description: Diverse profile illustrations transition to on-screen text highlighting AbbVie's 26 accepted abstracts across five rheumatic diseases at EULAR 2026, closing with a 'See you there!' message.]

[AbbVie @abbvie]

At #EULAR2026, we're presenting abstracts across our #rheumatology portfolio. We remain committed to building on our deep expertise and historic legacy in immunology research. Explore what drives us in immunology: https://t.co/H2rNBLvGuV

[AbbVie @abbvie]

#DYK migraine is a prevalent and debilitating neurological disease, impacting roughly 14% of the global population, with a higher incidence in women than men?

Learn more about a new indication for the acute treatment of migraine: https://t.co/FSnJbbMRL2

[AbbVie @abbvie]

At #ASCO26, we're inviting #HCPs to stop by our booth and share their unique connection to the #oncology community – showing how each connection strengthens our commitment to science for this community. Join us at Booth 27093.

[AbbVie @abbvie]

@plantinBetty @HHSGov Hi @plantinBetty, we saw your post and would like to connect. Can you DM us with more information?

[AbbVie @abbvie]

[Video description: On-screen text reads, “Oncology News.”]

[AbbVie @abbvie]

The @EU_Commission has granted AbbVie approval of our medicine as part of a combination regimen for previously untreated patients with chronic lymphocytic leukemia (#CLL). https://t.co/hXy1xSvBh1

[AbbVie @abbvie]

[Video description: On-screen text reads, "AbbVie data at ASCO 2026. AbbVie will share new data across: Small cell lung cancer, Ovarian cancer, Head and neck cancer, Prostate cancer, Multiple myeloma."]

[AbbVie @abbvie]

At this year's @ASCO Annual Meeting, our team will share new data across solid tumors and blood cancers from our novel platforms. Read more: https://t.co/45tL2BDVSS #ASCO26

[AbbVie @abbvie]

[Video description: Animation sharing key details about AbbVie’s presence at the 2026 American Society of Clinical Psychopharmacology Annual Meeting.]

[AbbVie @abbvie]

Next week we’ll be at #ASCP2026 presenting our latest data in psychiatric disorder research. Stop by our posters to see how our findings are supporting progress for people living with mental health conditions.

[AbbVie @abbvie]

...understanding of IBD and helping raise the standard of care through scientific innovation and a broad portfolio of marketed and investigational therapies.”]

[AbbVie @abbvie]

At #DDW2026, AbbVie is sharing new long-term #IBD data, including real-world evidence and clinical results reinforcing treatment efficacy, safety profiles, and durability across Crohn's Disease and Ulcerative Colitis. Learn more: https://t.co/yM0rZ6XnTw

[AbbVie @abbvie]

[Video description: Quote from Andrew Anisfeld, Ph.D., Vice President, Global Medical Affairs, Immunology, AbbVie. On-screen text reads, “As a leader in gastroenterology, AbbVie remains focused on advancing the...

[AbbVie @abbvie]

Join us live: Our Q1 2026 #earnings call is starting: https://t.co/HGS0e7Y6he $ABBV

[AbbVie @abbvie]

[Video description: AbbVie logo followed by graph animations, with text reading, "Q1 2026 Financial Results."]

[AbbVie @abbvie]

Our Q1 2026 #FinancialResults are in. See them here: https://t.co/qcCxPqLQ2g $ABBV #earnings

[AbbVie @abbvie]

[Video description: On-screen text reads, "Join us for our Q1 2026 Earnings Call & Webcast. April 29 at 8am CT."]

[AbbVie @abbvie]

Reminder: Join us tomorrow at 8am CT as we share our Q1 2026 #FinancialResults. https://t.co/HGS0e7Y6he #earnings $ABBV